ATP binding cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Health

ISSN Print: 1949-4998
ISSN Online: 1949-5005
www.scirp.org/journal/health
E-mail: health@scirp.org

Google-based Impact Factor: 0.74
Citations h5-index & Ranking*

Journals Menu

"ATP binding cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia"
written by Stuart S. Winter, Jerec Ricci, Li Luo, Debbie M. Lovato, Hadya M. Khawaja, Tasha Serna-Gallegos, Natalie DeBassige, Richard S. Larson,
published by Health, Vol.5 No.5A, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Screening of Translocation Ets-Leukemia-Acute-Myeloid-Leukemia-1 Fusion Gene and Expression Pattern of Multidrug Resistance Protein Protein in Children with …
	Journal of Biomaterials and Tissue Engineering, 2022

[2]	Étude du rôle et des mécanismes régulés par les intégrines bêta1 dans la chimiorésistance de la leucémie lymphoblastique aiguë de type T
	2021

[3]	Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
	Frontiers in …, 2021

[4]	Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells
	2021

[5]	Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
	2021

[6]	Pharmacogenomics insights into precision pediatric oncology
	Current opinion in …, 2021

[7]	Rab21, an Endocytic Rab GTPase, is Involved in Drug Resistance in Prostate Cancer Cells
	2020

[8]	Characterization of the kinetic cycle of an ABC transporter by single-molecule and cryo-EM analyses
	2020

[9]	Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells
	2020

[10]	Generation and characterization of an Abcc1 humanized mouse model (hABCC1flx/flx) with knockout capability
	2019

[11]	Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
	2019

[12]	Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
	Clinical Pharmacology & Therapeutics, 2018

[13]	S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
	Cancer management and research, 2018

[14]	A Novel Synthetic Dihydroindeno [1, 2-b] Indole Derivative (LS-2-3j) Reverses ABCB1-and ABCG2-Mediated Multidrug Resistance in Cancer Cells
	2018

[15]	Epigenetic drug combination overcomes bone marrow microenvironment-induced chemoprotection in pediatric acute lymphoblastic leukemia via modulation …
	2018

[16]	miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
	Oncotarget, 2017

[17]	ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1
	Cell, 2017

[18]	Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia
	2017

[19]	ABC 多药耐药基因表达与急性白血病相关性研究进展
	2016

[20]	Alpha2beta1 integrin in cancer development and chemoresistance
	Seminars in cancer biology, 2015

[21]	MRP1 and its role in anticancer drug resistance
	Drug metabolism reviews, 2015

[22]	原发性肝癌 P-糖蛋白表达与肝动脉插管栓塞化疗疗效的关系及临床意义.
	Journal of Xi'an Jiaotong University (Medical Sciences), 2015

[23]	儿童急性淋巴细胞白血病 MRP1 的表达及意义
	临床儿科杂志, 2014

[24]	Implication de l'intégrine alpha2beta1 liant le collagène dans la survie et la chimiorésistance des leucémies aiguës
	2014

[1]	Screening of Translocation Ets-Leukemia-Acute-Myeloid-Leukemia-1 Fusion Gene and Expression Pattern of Multidrug Resistance Protein Protein in Children with Acute Lymphoblastic Leukemia Journal of Biomaterials and Tissue Engineering, 2022 DOI:10.1166/jbt.2022.2864

[2]	Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor Frontiers in Pharmacology, 2021 DOI:10.3389/fphar.2021.771487

[3]	Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22115504

[4]	Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma Genome Medicine, 2021 DOI:10.1186/s13073-021-00920-z

[5]	Pharmacogenomics insights into precision pediatric oncology Current Opinion in Pediatrics, 2021 DOI:10.1097/MOP.0000000000001065

[6]	Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells Molecules, 2020 DOI:10.3390/molecules25112517

[7]	Characterization of the kinetic cycle of an ABC transporter by single-molecule and cryo-EM analyses eLife, 2020 DOI:10.7554/eLife.56451

[8]	Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia Cell Death & Disease, 2019 DOI:10.1038/s41419-019-1593-2

[9]	Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia Cell Death & Disease, 2019 DOI:10.1038/s41419-019-1593-2

[10]	Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia Cell Death & Disease, 2019 DOI:10.1038/s41419-019-1593-2

[11]	A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells Molecules, 2018 DOI:10.3390/molecules23123264

[12]	miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs Oncotarget, 2017 DOI:10.18632/oncotarget.17677

[13]	MRP1 and its role in anticancer drug resistance Drug Metabolism Reviews, 2015 DOI:10.3109/03602532.2015.1105253

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Health

Health

Journals Menu

Home

About SCIRP

Service

Policies